KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $86.0 million.

  • Progyny's Shares Outstanding (Weighted Average) fell 614.64% to $86.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.0 million, marking a year-over-year decrease of 614.64%. This contributed to the annual value of $91.5 million for FY2024, which is 468.68% down from last year.
  • Latest data reveals that Progyny reported Shares Outstanding (Weighted Average) of $86.0 million as of Q3 2025, which was down 614.64% from $85.8 million recorded in Q2 2025.
  • Progyny's Shares Outstanding (Weighted Average)'s 5-year high stood at $96.5 million during Q1 2024, with a 5-year trough of $85.5 million in Q1 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $91.7 million (2024), whereas its average is $91.3 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 458.34% in 2022, then crashed by 1138.58% in 2025.
  • Progyny's Shares Outstanding (Weighted Average) (Quarter) stood at $89.1 million in 2021, then increased by 3.47% to $92.2 million in 2022, then grew by 4.11% to $96.0 million in 2023, then decreased by 4.69% to $91.5 million in 2024, then fell by 5.97% to $86.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $86.0 million for Q3 2025, versus $85.8 million for Q2 2025 and $85.5 million for Q1 2025.